You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

Article info

Article menu

Download PDFPDF

XML
HIV/AIDS
Protocol
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

Authors

  • Cecilia T Costiniuk Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Zahra Saneei Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Jean-Pierre Routy Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Shari Margolese Canadian Institutes of Health Research Canadian HIV Trials Network, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Enrico Mandarino Canadian Institutes of Health Research Canadian HIV Trials Network, Vancouver, British Columbia, Canada WILLL Cannabis Group, Toronto, Canada PubMed articlesGoogle scholar articles
  • Joel Singer Canadian Institutes of Health Research Canadian HIV Trials Network, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Bertrand Lebouché Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada Department of Family Medicine, McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Joseph Cox Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada Department of Family Medicine, McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Jason Szabo Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada Department of Family Medicine, McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Marie-Josée Brouillette Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada Department of Psychiatry, McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Marina B Klein Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada Research Institute of McGill University Health Centre, Montreal, Canada PubMed articlesGoogle scholar articles
  • Nicolas Chomont Centre de Recherche du CHUM and Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Canada PubMed articlesGoogle scholar articles
  • Mohammad-Ali Jenabian Department of Biological Sciences and BioMed Research Centre, University of Quebec at Montreal (UQAM), Montreal, Quebec, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Cecilia T Costiniuk; cecilia.costiniuk{at}mcgill.ca
View Full Text

Citation

Costiniuk CT, Saneei Z, Routy J, et al
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
BMJ Open 2019;9:e024793. doi: 10.1136/bmjopen-2018-024793

Publication history

  • Received June 15, 2018
  • Revised October 17, 2018
  • Accepted November 8, 2018
  • First published January 17, 2019.
Online issue publication 
January 13, 2021
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.